These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16047033)

  • 1. Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy.
    Fritz M; Vats K; Goyal RK
    J Perinatol; 2005 Aug; 25(8):552-4. PubMed ID: 16047033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha for treatment of essential thrombocythemia during pregnancy: case report and review of the literature.
    Séror J; Sentilhes L; Lefebvre-Lacoeuille C; Marpeau L
    Fetal Diagn Ther; 2009; 25(1):136-40. PubMed ID: 19279390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review.
    Martinelli P; Martinelli V; Agangi A; Maruotti GM; Paladini D; Ciancia R; Rotoli B
    Am J Obstet Gynecol; 2004 Dec; 191(6):2016-20. PubMed ID: 15592285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful pregnancy and delivery during alpha-interferon therapy for essential thrombocythemia].
    Iki S; Usuki K; Kotaki M; Yamaguchi Y; Urabe A
    Rinsho Ketsueki; 1999 Nov; 40(11):1201-3. PubMed ID: 10624133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of interferon-alpha during pregnancy: effects on fetus.
    Hiratsuka M; Minakami H; Koshizuka S; Sato I
    J Perinat Med; 2000; 28(5):372-6. PubMed ID: 11125927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of essential thrombocythemia during pregnancy with interferon-alpha.
    Delage R; Demers C; Cantin G; Roy J
    Obstet Gynecol; 1996 May; 87(5 Pt 2):814-7. PubMed ID: 8677098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neonatal findings in children of drug-addicted mothers].
    Echevarría J; Callen M; Alustiza E; Orueta Y; Traba L; Paisán L
    An Esp Pediatr; 1983 Dec; 19(6):439-43. PubMed ID: 6666886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple gestation in an essential thrombocythemia patient treated with interferon-alpha.
    Nevruz O; Goktolga U; Avcu F; Ozsari L; Ural AU
    Acta Obstet Gynecol Scand; 2007; 86(7):893-5. PubMed ID: 17611839
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful maternal and fetal outcome in a rare case of essential Thrombocythemia with pregnancy using Interferon alpha.
    Singh N; Kumar S; Roy KK; Sharma V; Jalak A
    Platelets; 2012; 23(4):319-21. PubMed ID: 21913812
    [No Abstract]   [Full Text] [Related]  

  • 10. [Maternal corticotherapy . Pharmacology and effect on the fetus].
    Guillonneau M; Jacqz-Aigrain E
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):160-7. PubMed ID: 8690864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration of human AT-III in a case of lupus anticoagulant positive pregnancy].
    Nakamura N; Tanaka Y; Hirooka S; Hayashida M; Nasu T; Tsubakio T; Doi Y; Yoshihara W; Hirai T; Hosono T
    Rinsho Ketsueki; 1993 May; 34(5):649-55. PubMed ID: 8315836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential thrombocythemia and pregnancy.
    Pardini S; Careddu MF; Dore F; Bonfigli S; Gigliotti B; Longinotti M
    Haematologica; 1995; 80(4):392-3. PubMed ID: 7590511
    [No Abstract]   [Full Text] [Related]  

  • 13. Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors.
    Cantor B; Tyler T; Nelson RM; Stein GH
    J Reprod Med; 1980 May; 24(5):220-3. PubMed ID: 6772782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive glycemic control in diabetic pregnancy with intrauterine growth restriction is detrimental to fetus.
    Parikh RM; Joshi SR; Menon PS; Shah NS
    Med Hypotheses; 2007; 69(1):203-5. PubMed ID: 17141966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematological complications of neonatal lupus: case report and review of the literature.
    Chao MM; Luchtman-Jones L; Silverman RA
    J Pediatr Hematol Oncol; 2013 Nov; 35(8):e344-6. PubMed ID: 23128336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Occupational hazards as risk factors of perinatal pathology].
    Izmerov NF; Volkova ZA
    Vestn Akad Med Nauk SSSR; 1990; (7):26-9. PubMed ID: 2220047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neonatal toxicity of naphazoline administrated during pregnancy].
    Dageville C; Joly E; Spreux A; Berard E
    Therapie; 1995; 50(5):472-3. PubMed ID: 8571292
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon-alfa treatment of essential thrombocythemia during pregnancy.
    Iwashita T; Fujitani M; Yamamoto Y; Katsurada T; Yoshida Y
    Intern Med; 2006; 45(20):1161-4. PubMed ID: 17106162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.
    Beauverd Y; Radia D; Cargo C; Knapper S; Drummond M; Pillai A; Harrison C; Robinson S
    Haematologica; 2016 May; 101(5):e182-4. PubMed ID: 26819057
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypertriglyceridemia following treatment with interferon alpha in essential thrombocythemia].
    De Salvo L; Plumacher Z; Gómez O; Weir-Medina J; Paz L; Salas D
    Invest Clin; 1996 Sep; 37(3):177-81. PubMed ID: 8983355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.